Combination therapy for sleeping sickness: A wake-up call

Journal of Infectious Diseases

Volumn 195, Issue 3, 2007, Pages 311-313

  Pepin, Jacques ^a,b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; EFLORNITHINE; MELARSOPROL; NIFURTIMOX; PENTAMIDINE; SURAMIN;

AFRICAN TRYPANOSOMIASIS; AUTOIMMUNE DISEASE; BLOOD SMEAR; BRAIN DISEASE; BRAIN VASCULITIS; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONGO; DISEASE COURSE; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EDITORIAL; EPIDEMIC; GASTROINTESTINAL TOXICITY; HUMAN; MICROBIAL COLONIZATION; MONOTHERAPY; NEUROTOXICITY; NONHUMAN; PARASITEMIA; PERSISTENT INFECTION; PRIORITY JOURNAL; RELAPSE; SUDAN; SYMPTOMATOLOGY; TREATMENT OUTCOME; TRYPANOSOMA CRUZI; TRYPANOSOMA RHODESIENSE; UGANDA;

EID: 33846439350     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/510540     Document Type: Editorial

References (18)

1. Jelinek T, Bisoffi Z, Bonazzi L, et al. Cluster of African trypanosomiasis in travelers to Tanzanian national parks. Emerg Infect Dis 2002; 8:634-5.
2. Lejon V, Boelaert M, Jannin J, Moore A, Buscher P. The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa. Lancet Infect Dis 2003; 3:804-8.
3. Fevre E, Coleman PG, Odiit M, Magona JW, Welburn SC, Woolhouse MEJ. The origins of a new Trypanosoma brucei rhodesiense sleeping sickenes outbreak in eastern Uganda. Lancet 2001; 358:625-8.
4. Pepin J, Meda H. The epidemiology and control of African trypanosomiasis. Adv Parasitol 2001; 49:71-132.
5. World Health Organization. Human African trypanosomiasis (sleeping sickness): epidemiological update. Wkly Epidemiol Rec 2006; 81:71-80.
6. Lutumba P, Robays J, Miaka mia Bilenge C, et al. Trypanosomiasis control, Democratic Republic of Congo, 1993-2003. Emerg Infect Dis 2005; 11:1382-8.
7. Stanghellini A, Josenando T. The situation of sleeping sickness in Angola: a calamity. Trop Med Int Health 2001; 6:330-4.
8. Welburn SC, Picozzi K, Fevre E, et al. Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance associated (SRA) gene. Lancet 2001; 358:2017-9.
9. Pepin J, Donelson JE. African trypanosomiasis (sleeping sickness). In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens and practice. 2nd ed. Philadelphia: Churchill Livingstone, 2006: 1072-81.
10. Pepin J, Milord F. The treatment of human African trypanosomiasis. Adv Parasitol 1994; 33:1-47.
11. Pepin J, Khonde N, Maiso F, et al. Short-course eflornithine in Gambian sleeping sickness: a multicentre randomised controlled trial. Bull World Health Organ 2000; 78:1284-95.
12. Pepin J, Milord F, Mpia B, et al. An open clinical trial of nifurtimox for arseno-resistant T.b. gambiense sleeping sickness in central Zaire. Trans R Soc Trop Med Hyg 1989; 83: 514-7.
13. Coura JR, de Castro SL. A critical review of Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002; 97:3-24.
14. Viotti R, Vigliano C, Lococo B, et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 2006; 144:724-34.
15. Bisser S, N'Siesi FX, Lejon V, et al. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness. J Infect Dis 2007; 195:322-9 (in this issue).
16. Schmid C, Richer M, Bilengue MMC, et al. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II). J Infect Dis 2005; 191:1922-31.
17. Pepin J, Mpia B. Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis. Trans R Soc Trop Med Hyg 2006; 100:437-41.
18. Burri C, Nkunku S, Merolle A, Smith T, Blum J, Brun R. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. Lancet 2000; 355:1419-25.